Attached files
| file | filename |
|---|---|
| EX-31.1.1 - EX-31.1.1 - MADRIGAL PHARMACEUTICALS, INC. | a15-23265_4ex31d1d1.htm |
| 10-K/A - 10-K/A - MADRIGAL PHARMACEUTICALS, INC. | a15-23265_410ka.htm |
EXHIBIT 31.2.1
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF
SARBANES-OXLEY ACT OF 2002
I, Marc Schneebaum, certify that:
1. I have reviewed this Annual Report on Form 10-K of Synta Pharmaceuticals Corp.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
Date: April 29, 2016 |
/s/ MARC SCHNEEBAUM |
|
|
Marc Schneebaum |
|
|
Senior Vice President, Chief Financial Officer |